About Me

I specialize in the care of patients with Hodgkin and non-Hodgkin lymphoma. I am Clinical Director of the Division of Hematologic Oncology and I am board-certified in internal medicine, medical oncology, and hematology. Recognizing that advances in medicine come about as a result of clinical research, I am the Principal Investigator for a number of clinical trials aimed at improving the care of patients with lymphoma. The findings of several of the clinical trials I have led have changed the international standard of care.

Read more

My research has focused on improving the outcome of patients with poor-risk diffuse large B cell lymphoma (DLBCL) and Hodgkin lymphoma (HL). This effort has been conducted along two tracks. One effort is focused on improving therapy for patients with disease that has returned or is not responding to standard therapy (refractory disease), through the use of high-dose therapy and autologous stem cell transplantation as well as new agents that can be incorporated into such “salvage” therapy.

A second approach involves developing strategies to optimize the treatment of newly diagnosed DLBCL according to the likelihood of their disease recurring (“risk-adapted therapy”), using what we have learned by studying patients with relapsed or refractory disease. We design risk-adapted therapy according to a patient’s risk factors before treatment (clinical, molecular, or pathologic features of the disease) and the results of imaging studies.

  • Clinical Expertise: Hodgkin and Non-Hodgkin Lymphoma; Autologous Bone Marrow Transplantation for Lymphoma
  • Awards and Honors: New York Magazine Top Doctors (2015, 2016)
  • Languages Spoken: English
  • Education: MD, Wayne State University School of Medicine
  • Residencies: Bronx Municipal Hospital Center; Albert Einstein College of Medicine
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology; Hematology

New Patient Appointments

Making an appointment

Call 646-497-9137


Visit PubMed for a full listing of Craig H. Moskowitz’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.

Read more

Clinical Trials Led by Craig H. Moskowitz

Clinical Trials Co-Investigated by Craig H. Moskowitz


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more